SRZNW
Surrozen Inc. WarrantKey Statistics
About Surrozen Inc. Warrant
Surrozen Inc. is a cutting-edge biotechnology firm dedicated to creating innovative therapeutics for complex diseases via its proprietary platform, which emphasizes targeted biology. The company focuses on antibody therapeutics designed for tissue-specific delivery, allowing for precise modulation of critical biological pathways associated with a range of diseases. Surrozen has developed a promising pipeline of drug candidates at various stages of development, showcasing its commitment to transformative solutions in regenerative medicine. Leveraging a highly experienced team and strategic partnerships, Surrozen is well-positioned to drive significant advancements in patient care and redefine treatment paradigms in its field.
Fundamentals
| Revenue (TTM) | $7.49M |
| Gross Profit (TTM) | $-24.64M |
| EBITDA | $-42.69M |
| Operating Margin | -209.10% |
| Return on Equity | -62.80% |
| Return on Assets | -22.80% |
| Revenue/Share (TTM) | $0.81 |
| Book Value | $-19.21 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 408.60% |
| Shares Outstanding | 0 |
| Float | $5.09M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Historical Volatility
Volatility is currently expanding